These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 4769128)

  • 41. Comparison of trifluoperazine and molindone in chronic schizophrenic patients.
    Freeman H; Frederick AN
    Curr Ther Res Clin Exp; 1969 Nov; 11(11):670-6. PubMed ID: 4982301
    [No Abstract]   [Full Text] [Related]  

  • 42. Comparison of prazepam and placebo in the treatment of convalescing narcotic addicts.
    Sugerman AA; Miksztal MW; Freymuth HW
    J Clin Pharmacol New Drugs; 1971; 11(5):383-7. PubMed ID: 4935717
    [No Abstract]   [Full Text] [Related]  

  • 43. Assessment of drugs in schizophrenia. Assessment of psychiatric and social state. 20V.
    Leff J
    Br J Clin Pharmacol; 1976 Jun; 3(3 Suppl 2):385-90. PubMed ID: 987793
    [No Abstract]   [Full Text] [Related]  

  • 44. [Comparative study of 2 drugs and a placebo in chronic schizophrenia].
    Tetreault L
    Actual Pharmacol (Paris); 1969; 22():1-18. PubMed ID: 4927120
    [No Abstract]   [Full Text] [Related]  

  • 45. Methodological considerations in evaluating antianxiety drugs.
    Hollister LE
    J Clin Pharmacol J New Drugs; 1970; 10(1):12-8. PubMed ID: 4903952
    [No Abstract]   [Full Text] [Related]  

  • 46. Lack of effect on naloxone on schizophrenic symptoms.
    Janowsky DS; Segal DS; Bloom F; Abrams A; Guillemin R
    Am J Psychiatry; 1977 Aug; 134(8):926-7. PubMed ID: 879360
    [No Abstract]   [Full Text] [Related]  

  • 47. [Study of the effects of sulpiride on the mental state of 40 mental patients].
    Carrère J
    Ann Med Psychol (Paris); 1968 Nov; 2(4):560-74. PubMed ID: 5709615
    [No Abstract]   [Full Text] [Related]  

  • 48. A comparative trial of oxypertine and chlorpromazine in the treatment of acute psychoses.
    Wadzisz FJ
    Curr Ther Res Clin Exp; 1969 Dec; 11(12):784-92. PubMed ID: 4984044
    [No Abstract]   [Full Text] [Related]  

  • 49. Evaluation of clinical efficacy of pimozide as maintenance therapy in chronic schizophrenic patients.
    Singh AN
    Curr Ther Res Clin Exp; 1971 Nov; 13(11):695-705. PubMed ID: 5000717
    [No Abstract]   [Full Text] [Related]  

  • 50. Clinical and ergotherapeutic evaluation of fluspirilene (R 6218), a long-acting injectable neuroleptic, in chronic psychotic patients.
    Tanghe A; Vereecken JL
    Psychiatr Neurol Neurochir; 1971; 74(5):379-89. PubMed ID: 5138128
    [No Abstract]   [Full Text] [Related]  

  • 51. Antipsychotic efficacy of clozapine in correlation to changes in catecholamine metabolism in man.
    Ackenheil M; Beckmann H; Greil W; Hoffmann G; Markianos E; Raese J
    Adv Biochem Psychopharmacol; 1974; 9(0):647-57. PubMed ID: 4836227
    [No Abstract]   [Full Text] [Related]  

  • 52. Double-blind evaluation of prazepam, chlordiazepoxide and placebo in non-psychotic patients with anxiety and tension: some methodological considerations.
    Kingstone E; Villeneuve A; Kossatz I
    Curr Ther Res Clin Exp; 1969 Mar; 11(3):106-14. PubMed ID: 4976238
    [No Abstract]   [Full Text] [Related]  

  • 53. The neuroleptics. 8. Clinical methodology.
    Ban TA; Bordeleau JM; Debray HR; Hamilton M; Ito H; Overall JE; Pichot P; Reda G; Tetreault L; Volmat R; Wiart C
    Mod Probl Pharmacopsychiatry; 1970; 5():133-40. PubMed ID: 4949817
    [No Abstract]   [Full Text] [Related]  

  • 54. The positive and negative symptoms of schizophrenia: patterns of response to depot neuroleptic treatment.
    Martyns-Yellowe IS
    West Afr J Med; 1994; 13(4):200-3. PubMed ID: 7756183
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical experience with fluspirilene in psychoses.
    Svestka J; Náhunek K; Hádlík J; Rodová A
    Act Nerv Super (Praha); 1971; 13(3):173-4. PubMed ID: 5113825
    [No Abstract]   [Full Text] [Related]  

  • 56. A pilot study of CI-601 in chronic schizophrenics.
    Sugerman AA; Herrmann J; O'Hara M
    Curr Ther Res Clin Exp; 1968 Oct; 10(10):529-32. PubMed ID: 4971468
    [No Abstract]   [Full Text] [Related]  

  • 57. Assessment of drugs in schizophrenia. Discussion on assessment of psychiatric and social state.
    Malm U
    Br J Clin Pharmacol; 1976 Jun; 3(3 Suppl 2):391-3. PubMed ID: 990150
    [No Abstract]   [Full Text] [Related]  

  • 58. Objective therapy predictors in depression: a multivariate approach.
    Weckowicz TE; Yonge KA; Cropley AJ; Muir W
    J Clin Psychol; 1971 Jan; 27(1):4-29. PubMed ID: 5539326
    [No Abstract]   [Full Text] [Related]  

  • 59. Somatosensory-evoked potential changes during haloperidol treatment of chronic schizophrenics.
    Saletu B; Saletu M; Itil T; Marasa J
    Biol Psychiatry; 1971; 3(4):299-307. PubMed ID: 5163816
    [No Abstract]   [Full Text] [Related]  

  • 60. [Neuroleptic therapy in schizophrenia].
    Sedvall G; Nybäck H
    Nord Psykiatr Tidsskr; 1972; 26(6):323-40. PubMed ID: 4404495
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.